13D Filing: Sutter Hill Ventures and Cardica Inc (CRDC)

Page 1 of 14

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sutter Hill Ventures, a California Limited Partnership 296,614 0 296,614 0 296,614 3.3%
William H. Younger, Jr 100,782 296,614 100,782 296,614 397,396 4.5%
Tench Coxe 70,711 296,614 70,711 296,614 367,325 4.1%
James N. White 22,494 296,614 22,494 296,614 319,108 3.6%
Jeffrey W. Bird 20,610 296,614 20,610 296,614 317,224 3.6%
Michael L. Speiser 21,947 296,614 21,947 296,614 318,561 3.6%
Stefan A. Dyckerhoff 4,264 296,614 4,264 296,614 300,878 3.4%
Samuel J. Pullara III 4,264 296,614 4,264 296,614 300,878 3.4%

Page 1 of 14 SEC Filing



 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
     
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Cardica, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
14141R309
(CUSIP Number)
Robert Yin
Sutter Hill Ventures
755 Page Mill Rd., Suite A-200
Palo Alto, CA  94304
650-493-5600
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 26, 2016
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 1 of 14